Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer
Erratum

Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer

Fengrui Xu1,2, Zefei Jiang1

1Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China; 2Department of Breast Oncology, Academy of Military Medical Sciences, Beijing 100089, China

Correspondence to: Zefei Jiang. Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No. 8 East Street, Fengtai District, Beijing 100071, China. Email: jiangzefei@csco.org.cn.

doi: 10.21037/atm-2020-21


Erratum to: Ann Transl Med 2020;8:138.


Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer

In the article entitled “Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer” (1), the affiliation of Fengrui Xu should be corrected as follows: 1Department of Breast Oncology, Academy of Military Medical Sciences, Beijing 100089, China; 2Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China

We regret the errors.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Xu F, Jiang Z. Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer. Ann Transl Med 2020;8:138. [Crossref] [PubMed]
Cite this article as: Xu F, Jiang Z. Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer. Ann Transl Med 2020;8(10):658. doi: 10.21037/atm-2020-21